🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to assess the safety, effectiveness, and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-14
Trial ID
NCT04886154
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
The bacterium (germ) Neisseria meningitidis causes meningitis and blood poi...
Status
Completed
Location
Oxford Vaccine Group
Start Date
2012-12
Trial ID
NCT01593514
Treatments Being Tested
A phase 2/3 study to determine the efficacy, safety and immunogenicity of t...
Status
Completed
Location
University Hospital Southampton NHS Foundation Trust
Start Date
2020-05-28
Trial ID
NCT04400838
Treatments Being Tested
A phase I/II single-blinded, randomised, multi-centre study to determine ef...
Status
Completed
Location
University Hospital Southampton NHS Foundation Trust
Start Date
2020-04-23
Trial ID
NCT04324606
The purpose of the current study is to evaluate whether there is immune int...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-09
Trial ID
NCT03587207
Treatments Being Tested
This is Phase IV, Open label, Multicenter study. Subject's parents and/or l...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-07-13
Trial ID
NCT02446691
Treatments Being Tested
There is evidence of waning immunity in individuals vaccinated against meni...
Status
Completed
Location
Multiple General Practice surgeries
Start Date
2012-06
Trial ID
NCT01192997
Treatments Being Tested
This study compares the safety and immunogenicity profile of several travel...
Status
Completed
Location
Centrum ockovani a cestovni mediciny (Vaccination and Travel Medicine Centre) Poliklinika II
Start Date
2011-11
Trial ID
NCT01466387
The purpose of the study is to characterize the safety and immunogenicity o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-05
Trial ID
NCT00471081
Treatments Being Tested